|
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies |
|
|
|
Titel: |
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies |
Auteur: |
Peyrin-Biroulet, Laurent Colombel, Jean-Frederic Louis, Edouard Ferrante, Marc Motoya, Satoshi Panaccione, Remo Torres, Joana Ungaro, Ryan C. Kligys, Kristina Kalabic, Jasmina Zambrano, Javier Zhang, Yafei D'Haens, Geert |
Verschenen in: |
Gastro Hep advances |
Paginering: |
Jaargang 3 () nr. 4 pagina's 539-550 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|